BC Week In Review | May 25, 2018
Financial News

Consonance, Jay Mohr partner to invest in deprioritized therapeutics

Through a collaboration with biotech executive Jay Mohr, Consonance Capital Partners (New York, N.Y.) plans to make its first therapeutics investments out of its $500 million private equity fund, with the aim of increasing the...
BC Extra | May 22, 2018
Financial News

Consonance, Jay Mohr partner to invest in deprioritized therapeutics

Through a collaboration with biotech executive Jay Mohr, Consonance Capital Partners plans to make its first therapeutics investments out of its $500 million private equity fund, with the aim of increasing the profitability of deprioritized...
BC Week In Review | Nov 25, 2013
Company News

3-V Biosciences management update

3-V Biosciences Inc. , Menlo Park, Calif.   Business: Cancer, Infectious   Hired: William McCulloch as CMO, formerly CMO of Gloucester Pharmaceuticals Inc. , which Celgene Corp. acquired  ...
BioCentury | Aug 5, 2013
Strategy

Future-proofing MM

Celgene Corp. 's deal with Acetylon Pharmaceuticals Inc. hinges on the expectation that epigenetic therapy combinations will become mainstays of multiple myeloma treatment and gives Celgene first crack at ACY-1215 - the most advanced HDAC6 inhibitor...
BC Week In Review | Apr 8, 2013
Company News

Celgene, Cyclacel cancer news

Cyclacel will sell Celgene patents covering the use of romidepsin injection in T cell lymphomas for $5.5 million. In conjunction, a judge in the U.S. District Court for the District of Delaware granted the companies'...
BioCentury | Jan 7, 2013
Finance

Novo's public moves

With small cap public biotechs living in a challenging financial environment, Novo A/S 's Novo Ventures group sees an opportunity to put its money to work. The group thinks depressed valuations mark an attractive entry...
BC Week In Review | Dec 3, 2012
Clinical News

Istodax romidepsin regulatory update

EMA's CHMP confirmed its negative opinion against approval of Istodax romidepsin from Celgene to treat peripheral T cell lymphoma (PTCL) in patients who have received >=2 prior therapies. The company requested a re-examination of the...
BC Week In Review | Jul 23, 2012
Clinical News

Istodax romidepsin regulatory update

EMA's CHMP recommended against approval of Istodax to treat peripheral T cell lymphoma (PTCL) in patients who have received >=2 prior therapies. The committee said the data in the application did not include comparators and...
BioCentury | Jan 30, 2012
Strategy

Committing to covalency

After building a business by combining in-house discovery with early stage licensing deals and opportunistic later-stage M&A, Celgene Corp. 's plan to buy Avila Therapeutics Inc. marks its first acquisition of a small molecule discovery...
BioCentury | Oct 10, 2011
Finance

Venture's stress

Prospect Venture Partners created surprise and unease last week when it decided $150 million was not enough to support a new fund and released its LPs from their commitments. It now remains to be seen...
Items per page:
1 - 10 of 101
BC Week In Review | May 25, 2018
Financial News

Consonance, Jay Mohr partner to invest in deprioritized therapeutics

Through a collaboration with biotech executive Jay Mohr, Consonance Capital Partners (New York, N.Y.) plans to make its first therapeutics investments out of its $500 million private equity fund, with the aim of increasing the...
BC Extra | May 22, 2018
Financial News

Consonance, Jay Mohr partner to invest in deprioritized therapeutics

Through a collaboration with biotech executive Jay Mohr, Consonance Capital Partners plans to make its first therapeutics investments out of its $500 million private equity fund, with the aim of increasing the profitability of deprioritized...
BC Week In Review | Nov 25, 2013
Company News

3-V Biosciences management update

3-V Biosciences Inc. , Menlo Park, Calif.   Business: Cancer, Infectious   Hired: William McCulloch as CMO, formerly CMO of Gloucester Pharmaceuticals Inc. , which Celgene Corp. acquired  ...
BioCentury | Aug 5, 2013
Strategy

Future-proofing MM

Celgene Corp. 's deal with Acetylon Pharmaceuticals Inc. hinges on the expectation that epigenetic therapy combinations will become mainstays of multiple myeloma treatment and gives Celgene first crack at ACY-1215 - the most advanced HDAC6 inhibitor...
BC Week In Review | Apr 8, 2013
Company News

Celgene, Cyclacel cancer news

Cyclacel will sell Celgene patents covering the use of romidepsin injection in T cell lymphomas for $5.5 million. In conjunction, a judge in the U.S. District Court for the District of Delaware granted the companies'...
BioCentury | Jan 7, 2013
Finance

Novo's public moves

With small cap public biotechs living in a challenging financial environment, Novo A/S 's Novo Ventures group sees an opportunity to put its money to work. The group thinks depressed valuations mark an attractive entry...
BC Week In Review | Dec 3, 2012
Clinical News

Istodax romidepsin regulatory update

EMA's CHMP confirmed its negative opinion against approval of Istodax romidepsin from Celgene to treat peripheral T cell lymphoma (PTCL) in patients who have received >=2 prior therapies. The company requested a re-examination of the...
BC Week In Review | Jul 23, 2012
Clinical News

Istodax romidepsin regulatory update

EMA's CHMP recommended against approval of Istodax to treat peripheral T cell lymphoma (PTCL) in patients who have received >=2 prior therapies. The committee said the data in the application did not include comparators and...
BioCentury | Jan 30, 2012
Strategy

Committing to covalency

After building a business by combining in-house discovery with early stage licensing deals and opportunistic later-stage M&A, Celgene Corp. 's plan to buy Avila Therapeutics Inc. marks its first acquisition of a small molecule discovery...
BioCentury | Oct 10, 2011
Finance

Venture's stress

Prospect Venture Partners created surprise and unease last week when it decided $150 million was not enough to support a new fund and released its LPs from their commitments. It now remains to be seen...
Items per page:
1 - 10 of 101